Cagrilintide 5mg
Lab-made version of amylin, a hormone released alongside insulin.
- Sold as
- Box of 10 vials, 5mg each
- Form
- Freeze-dried (lyophilised) powder in a sealed, plain unlabelled vial
About Cagrilintide
What it is
Cagrilintide is a man-made, long-acting version of amylin. Amylin is a hormone the pancreas releases together with insulin after a meal.
How it works
It binds to amylin receptors and also to calcitonin receptors. In the body, these receptors are part of the signals linked to fullness and to how fast the stomach empties.
What it has been studied for
- appetite and weight regulation
- blood sugar control in type 2 diabetes
- combination with semaglutide (CagriSema)
Status
Not an approved medicine in South Africa. Novo Nordisk has tested it in phase 3 trials, mostly combined with semaglutide as 'CagriSema', and asked the US FDA to approve CagriSema in December 2025. We could not confirm whether that review is finished, so please check the latest status yourself. This product is not a medicine.
Storage
Keep the vial sealed in a fridge (2-8 °C), away from light and moisture. For longer storage, many people keep it in a freezer (-20 °C). Do not leave it in heat or direct sun.
For research use only. Not a medicine, not for human or veterinary use. This page explains the compound for researchers and trade buyers; it is not medical advice.